TCL Archive In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard. August 5, 2005
TCL Archive In Brief: Bristol Has Change Of Heart, Agrees To Supply NCI With VP-16 Free For Group C Distribution July 16, 1982
TCL Archive Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity October 28, 2011
TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. April 30, 2004
TCL Archive Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner. July 4, 2003
